Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
van Brummelen, Emilie M. J.
~ 100  Ergebnisse:
Personensuche X
?
1

Safety and pharmacokinetics of multiple dosing with inhalab..:

Thijssen, Eva ; den Heijer, Jonas M. ; Puibert, David...
Parkinsonism & Related Disorders.  97 (2022)  - p. 84-90 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Integration of healthy volunteers in early phase clinical t..:

Radanovic, Igor ; Klarenbeek, Naomi ; Rissmann, Robert...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Touchscreen-based finger tapping: Repeatability and configu..:

Makai-Bölöni, Soma ; Thijssen, Eva ; van Brummelen, Emilie M. J....
PLOS ONE.  16 (2021)  12 - p. e0260783 , 2021
Link: https://doi.org/10.1371/..
 
?
4

A phase I, randomized, double‐blind, placebo‐controlled, si..:

Hijma, Hemme J. ; van Brummelen, Emilie M. J. ; Siebenga, Pieter S..
Clinical and Translational Science.  15 (2021)  4 - p. 981-993 , 2021
Link: https://doi.org/10.1111/..
 
?
5

First‐in‐human trial to assess the safety, tolerability, ph..:

Moss, Laurence M. ; Berends, Cecile L. ; van Brummelen, Emilie M. J....
British Journal of Clinical Pharmacology.  88 (2021)  1 - p. 103-114 , 2021
Link: https://doi.org/10.1111/..
 
?
6

Phase 1 clinical trial of losmapimod in facioscapulohumeral..:

Mellion, Michelle L. ; Ronco, Lucienne ; Berends, Cecile L....
British Journal of Clinical Pharmacology.  87 (2021)  12 - p. 4658-4669 , 2021
Link: https://doi.org/10.1111/..
 
?
7

Healthy volunteers in first‐in‐human oncology drug developm..:

de las Heras, Begoña ; Bouyoucef‐Cherchalli, Dalila ; Reeve, Lesley...
British Journal of Clinical Pharmacology.  88 (2021)  4 - p. 1773-1784 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Phase I study of lapatinib plus trametinib in patients with..:

Huijberts, Sanne C. F. A. ; van Geel, Robin M. J. M. ; van Brummelen, Emilie M. J....
Cancer Chemotherapy and Pharmacology.  85 (2020)  5 - p. 917-930 , 2020
Link: https://doi.org/10.1007/..
 
?
9

First-in-human administration of a live-attenuated RSV vacc..:

Verdijk, Pauline ; van der Plas, Johan L. ; van Brummelen, Emilie M.J....
Vaccine.  38 (2020)  39 - p. 6088-6095 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Phase 1 study of the pan-HER inhibitor dacomitinib plus the..:

van Geel, Robin M. J. M. ; van Brummelen, Emilie M. J. ; Eskens, Ferry A. L. M....
British Journal of Cancer.  122 (2020)  8 - p. 1166-1174 , 2020
Link: https://doi.org/10.1038/..
 
?
11

Phase I Study of Afatinib and Selumetinib in Patients with ..:

Brummelen, Emilie M.J. ; Huijberts, Sanne ; Herpen, Carla...
The Oncologist.  26 (2020)  4 - p. 290-e545 , 2020
Link: https://doi.org/10.1002/..
 
?
12

Quantification of tremor using consumer product acceleromet..:

van Brummelen, Emilie M. J. ; Ziagkos, Dimitrios ; de Boon, Wadim M. I....
Journal of Clinical Movement Disorders.  7 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
13

Prevalent levels of RSV serum neutralizing antibodies in he..:

Van Der Plas, Johan L. ; Verdijk, Pauline ; Van Brummelen, Emilie M. J....
Human Vaccines & Immunotherapeutics.  16 (2019)  6 - p. 1322-1326 , 2019
Link: https://doi.org/10.1080/..
 
?
14

A phase Ib study of GSK3052230, an FGF ligand trap in combi..:

van Brummelen, Emilie M. J. ; Levchenko, Evgeny ; Dómine, Manuel...
Investigational New Drugs.  38 (2019)  2 - p. 457-467 , 2019
Link: https://doi.org/10.1007/..
 
?
15

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in pa..:

van Brummelen, Emilie M.J. ; Huisman, Marc C. ; de Wit-van der Veen, Linda J....
Oncotarget.  9 (2018)  37 - p. 24737-24749 , 2018
Link: https://doi.org/10.18632..
 
1-15